Z. A. Abdel Rahman

Impact of Novel Targeted Therapies and Cytogenetic Risk Groups on Outcome After Allogeneic Transplantation for Adult ALL.

M. Heckman, Liuyan Jiang, V. Roy, 2021, Transplantation and cellular therapy.

Donor cell‐derived chronic myelomonocytic leukemia presenting after allogeneic hematopoietic cell transplantation for T‐cell acute lymphoblastic leukemia

R. Robetorye, J. Foran, Zaid H Abdel Rahman, 2020, Clinical case reports.

Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors

O. Frankfurt, N. Daver, J. Altman, 2022, American journal of hematology.

Primary peritoneal myeloid sarcoma in association with CBFB/MYH11 fusion

Liuyan Jiang, Justin J. Kuhlman, J. Foran, 2021, Leukemia research reports.

Comparative study of therapy‐related and de novo adult b‐cell acute lymphoblastic leukaemia

M. Heckman, W. Hogan, R. Ketterling, 2021, British journal of haematology.

Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS)

E. So, D. Dingli, S. Ansell, 2022, Blood Cancer Journal.

Clinical impact of metformin in diabetic diffuse large B-cell lymphoma patients: a case-control study

P. Kuriakose, Yaser Alkhatib, Z. A. Abdel Rahman, 2017, Leukemia & lymphoma.

Outcomes of patients with thrombocytopenia evaluated at hematology subspecialty clinics.

Zaid H Abdel Rahman, V. Donthireddy, K. Miller, 2021, Hematology/oncology and stem cell therapy.